Thakor et al., 2014 - Google Patents
Synthesis and cell line study of pyrazole substituted coumarin derivativesThakor et al., 2014
View PDF- Document ID
- 8199255040227470380
- Author
- Thakor T
- Savjani J
- Publication year
- Publication venue
- Int. J. Pharm. Tech. Res
External Links
Snippet
Pyrazole substituted coumarin derivatives were synthesised via multi-component reaction namely 3-(4-substituted phenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde containing 4- hydroxy-2H-chromen-2-one and 4-methyl-2-oxo-2H-chromen-7-yl acetate by conventional …
- 125000003226 pyrazolyl group 0 title abstract description 6
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burmaoglu et al. | Synthesis, biological evaluation and molecular docking studies of bis-chalcone derivatives as xanthine oxidase inhibitors and anticancer agents | |
| CN101074229B (en) | 7-azaindirubin and 7-azaisoindigo derivative production and pharmaceutical use | |
| Gao et al. | Synthesis and anticancer activity of some novel 2-phenazinamine derivatives | |
| CN110002987B (en) | Phenylallylidene cyclohexenone derivative, preparation method and application thereof | |
| Thakor et al. | Synthesis and cell line study of pyrazole substituted coumarin derivatives | |
| CN102627685B (en) | Nitric oxide-donating glutathione compound, preparation method and medical purpose thereof | |
| CN108299398B (en) | Carbazole-containing quinazoline derivative with anti-tumor activity and pharmaceutical application thereof | |
| CN101332198B (en) | Pharmaceutical use of 6-aryl-3-substituted carbonyl pyridine compound | |
| Reddy et al. | Molecular hybridization-based design, PASE three-component synthesis, antiproliferative activity and molecular modelling studies of N, N-dimethylaminophenyl substituted 5H-chromeno [2, 3-b] pyridine analogs | |
| CN108191866B (en) | A kind of ADT-OH class H2S donor and rutaecarpin splicing object and its preparation method and application | |
| US11786520B2 (en) | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | |
| CN112409431B (en) | Cytarabine structural analogue, and preparation method and application thereof | |
| US9889128B2 (en) | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | |
| CN110028478A (en) | The preparation method and purposes of the 4,7- position split nitrogen mustard derivatives of a kind of brefeldin A | |
| CN104693194B (en) | 3 (2 acrylate) 3 ˊ nitro isoxazole Oxoindole compounds and preparation method and application | |
| CN110028477A (en) | The preparation method and purposes of the 4- position split nitrogen mustard derivatives of a kind of brefeldin A | |
| CN106565657A (en) | Hesperetin cinnamate compound with anti-tumor activity and synthetic method thereof | |
| CN101230015B (en) | Substituted cinnamic acid derivatives containing amine substituent group and tumor cytotoxicity thereof | |
| CN104926804A (en) | Compounds with anti-tumor effect, and preparation method and application of compounds | |
| Kuran et al. | Synthesis and biological activity of a novel series of 6, 7-dimethoxyquinazoline-2, 4 (1H, 3H)-dione derivatives | |
| CN112174872A (en) | Indole benzoquinone derivative as fluorescent and photoacoustic imaging agent and application thereof | |
| US20240066023A1 (en) | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | |
| CN115557889A (en) | 2-aryl-3, 4-dihydroisoquinoline derivative and application thereof in preparing antitumor drugs | |
| CN101474186A (en) | 2,3,4,7,8-polysubstituted naphthyridine [4,3-d] pyridine derivates with anti-tumor activity | |
| CN108395431B (en) | A kind of rutaecarpin split ADT-OH class H2S donor derivative and its preparation method and application |